Skip to main content

Table 4 Serious adverse events (SAEs) in the safety population (incidence ≥ 1.0%)

From: Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

Preferred term Percent of patients N = 902
Patients with at least 1 SAE 15.1
Occurring in ≥ 1% of patients  
 Syncope 1.3
 Urinary tract infection 1.2
 Fall 1.0